|
|
|
Insider
Information: |
Florence Anthony A. Jr. |
Relationship: |
|
City: |
Chevy Chase |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
36 |
|
Direct
Shares |
3,512,542 |
|
Indirect Shares
|
284,402,988 |
|
|
Direct
Value |
$81,703 |
|
|
Indirect Value
|
$568,846,527 |
|
|
Total
Shares |
287,915,530 |
|
|
Total
Value |
$568,928,230 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
3
|
Stock
price went up :
|
3
|
1
|
Stock
price went down : |
2
|
2
|
|
|
|
Gain/Loss Ratio : |
1.5
|
1.5
|
Percentage
Gain/Loss : |
38.2%
|
148.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2022-10-19 |
354 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
3,210 |
2020-09-14 |
10,260 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
1,924 |
2018-02-13 |
13,895 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2023-06-13 |
384 |
2023-06-13 |
11,348 |
Premium* |
|
Casper Sleep Inc. |
CSPR |
Director, 10% Owner |
2022-01-25 |
0 |
2022-01-25 |
0 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
0 |
2021-05-24 |
0 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
806 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
Robinhood Markets, Inc. |
HOOD |
Director |
2021-08-02 |
0 |
2022-05-03 |
0 |
Premium* |
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2022-01-06 |
3,507,024 |
2021-12-30 |
0 |
Premium* |
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
0 |
2022-11-16 |
1,047 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
0 |
2022-12-21 |
0 |
Premium* |
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KRRO |
Korro Bio |
|
|
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
KRRO |
Korro Bio |
10% Owner |
|
2023-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,072,936 |
|
- |
|
SVRA |
Savara Inc |
10% Owner |
|
2023-07-17 |
4 |
B |
$3.00 |
$999,999 |
I/I |
333,333 |
24,471,264 |
1.5 |
% |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
384 |
384 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
41,348 |
11,348 |
0 |
- |
|
ACLX |
Arcellx, Inc. |
10% Owner |
|
2022-12-21 |
4 |
S |
$30.74 |
$5,502 |
I/I |
(179) |
0 |
0 |
- |
|
ACLX |
Arcellx, Inc. |
10% Owner |
|
2022-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
30,179 |
179 |
0 |
- |
|
ACLX |
Arcellx, Inc. |
10% Owner |
|
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,294,207) |
0 |
0 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(11,867,242) |
0 |
0 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
176,425 |
1,047 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,012,605 |
354 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
0 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2022-05-25 |
4 |
S |
$0.08 |
$362,720 |
I/I |
(4,445,093) |
0 |
0 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2022-05-24 |
4 |
S |
$0.07 |
$387,943 |
I/I |
(5,931,843) |
4,445,093 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-05-03 |
4 |
S |
$10.06 |
$19,640 |
I/I |
(1,952) |
0 |
0 |
% |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-05-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(24,180,253) |
0 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-05-02 |
4 |
A |
$0.00 |
$0 |
I/I |
359,296 |
1,952 |
0 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2022-04-11 |
4 |
B |
$1.90 |
$6,802,999 |
I/I |
3,580,526 |
948,948 |
1.5 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-01-31 |
4 |
S |
$14.22 |
$29,598 |
I/I |
(2,082) |
0 |
0 |
% |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-01-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(24,223,741) |
0 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
359,296 |
2,082 |
0 |
- |
|
CSPR |
Casper Sleep Inc. |
Director |
|
2022-01-25 |
4 |
D |
$6.90 |
$230,419 |
D/D |
(33,394) |
0 |
0 |
- |
|
CSPR |
Casper Sleep Inc. |
Director |
|
2022-01-25 |
4 |
D |
$6.90 |
$42,935,264 |
I/I |
(6,222,502) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|